Physician profile
Claire Wright
NPI 1184010308
$2,286.06
in general payments reported to CMS, 2019-2025
19 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $83.49 · 2021: $556 · 2022: $442 · 2023: $250 · 2024: $417 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $749.24 | 2019-2024 | Clareon, Hydrus Microstent, Rocklatan |
| Eyepoint US, INC. | $237.54 | 2021-2022 | |
| Abbvie INC. | $203.97 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $184.07 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Aerie Pharmaceuticals, INC. | $177.40 | 2020-2021 | |
| Allergan, INC. | $171.89 | 2020-2021 | |
| Sight Sciences, INC. | $92.79 | 2022 | |
| Ocular Therapeutix, INC. | $74.25 | 2025 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $71.67 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $57.89 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $55.52 | 2024-2025 | Tepezza |
| Thea Pharma INC. | $50.78 | 2024-2025 | Iyuzeh |
| Biotissue Holdings INC. | $45.80 | 2025 | |
| Novartis Pharmaceuticals Corporation | $31.70 | 2019 | |
| Alimera Sciences, INC. | $21.32 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $19.11 | 2023 | |
| Immunocore Limited | $15.86 | 2025 | Kimmtrak |
| New World Medical,INC. | $14.16 | 2024 | Streamline, Kahook Dual Blade, Clearpath |
| Sun Pharmaceutical Industries INC. | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.